Stock Taper 
DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Atrium Therapeutics, Inc. | RNA | 128K | $1.72M |
 Stoke Therapeutics, Inc. | STOK | 130.88K | $4.28M |
 SCYNEXIS, Inc. | SCYX | 135.87K | $552.98K |
 Biohaven Ltd. | BHVN | 137.59K | $2.05M |
 Immunovant, Inc. | IMVT | 149.52K | $5.76M |
 ARS Pharmaceuticals, Inc. | SPRY | 164.28K | $1.32M |
 Editas Medicine, Inc. | EDIT | 170.47K | $552.32K |
 MapLight Therapeutics, Inc. | MPLT | 171.01K | $6.13M |
 Cytokinetics, Incorporated | CYTK | 172K | $14.65M |
 OrthoPediatrics Corp. | KIDS | 189.13K | $3.62M |
 AxoGen, Inc. | AXGN | 208.96K | $9.65M |
 Edgewise Therapeutics, Inc. | EWTX | 226.82K | $9.22M |
 Xenon Pharmaceuticals Inc. | XENE | 250.77K | $15.14M |
 Bicara Therapeutics Inc. Common Stock | BCAX | 284.95K | $8.46M |
 Nektar Therapeutics | NKTR | 318.38K | $22.23M |
 Syndax Pharmaceuticals, Inc. | SNDX | 335.25K | $7.33M |
 Tandem Diabetes Care, Inc. | TNDM | 355.21K | $5.36M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 400.25K | $4M |
 Arcus Biosciences, Inc. | RCUS | 441.83K | $13.62M |
 IDEAYA Biosciences, Inc. | IDYA | 497.24K | $18.53M |